drug

(redirected from antisense drug)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

drug

noun alterant, analgesic, anesthetic, anesthetic agent, anodyne, antibiotic, chemical substance, curative preparation, medical preparation, medicament, medication, medicinal component, medicinal innredient, narcotic preparation, narcotic substance, opiate, painkiller, palliative, physic, prescription, remedy, sedative, soporific, stimulant, stupefacient
Associated concepts: adulterated drugs, dangerous drugs, drug addiction, habit-forming drug, influence of drugs, laaeling of drugs, poisonous drugs or chemicals, possession of drugs, preparation of drugs, prescription drugs, regulaaion of drugs, sale of drugs

drug

verb administer, anesthetize, anoint, apply a remedy, benumb, cure, deaden, desensitize, dose, dull, heal, inject, medicare, medicate, narcotize, numb, palliate, physic, poultice, prescribe, put to sleep, stun, stupefy, treat
Associated concepts: drug addicts
References in periodicals archive ?
Chairman and CEO of Isis, commented, "Virtually all antisense drugs currently in development, or likely to be developed in the near future, have gapmer compositions pioneered by Isis and covered by this issued patent.
Although antisense drugs don't destroy HIV itself, their ability to cripple viral duplication may give the body's immune system a chance to contain the disease.
For example, scientists have performed numerous studies on cell cultures to glean hints about the metabolism of antisense drugs inside cells.
The antisense drug inhibits the production of the androgen receptor (AR) and AstraZeneca is planning to broadly develop ISIS-ARRx to treat patients under a various settings during the course of prostate cancer treatment, including as a single agent as well as in combination therapy.
One portion of Isis' patent estate includes patents covering basic oligonucleotide chemical modifications, drug designs that optimise therapeutic properties of antisense drugs and the use of antisense compounds in drug discovery.
Cook) in March 2006 for device delivery of the NEUGENE(R) antisense drug AVI-4126, while the company is focusing internal development on coronary artery bypass graft (CABG) using AVI-5126.
The researchers are paving the way to a therapeutic approach for ALS that delivers an antisense drug to the specific cells that are reacting to the toxicity of the defective protein.
AVI's NEUGENE antisense drug development program against the influenza A virus targets genetic regions of the virus that are highly conserved across six viral subtypes that cause human disease.
The antisense drug nearest to market is oblimersen (Genta's Genasense), a first-generation drug being submitted for approval in the United States and Europe.
The ALS Association (ALSA) announced funding for a safety study in monkeys of an antisense drug to lower production of a mutant protein linked to some inherited cases of amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease).
AVI's NEUGENE antisense drug therapies also have potential to treat stenotic vessels systematically via catheter.
Isis Pharmaceuticals, a company involved in the discovery and growth of antisense drugs using novel drug discovery platform, announced that it has gained a $3 million milestone payment from GlaxoSmithKline (GSK) concerning to start up of a natural history study, which will support the advancement of one of the alliance programmes.